Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human PON3 ELISA Kit (AC3850)
Cat.#: ASET-2439
Specifications
Description Human PON3 ELISA Kit allows for the in vitro quantitative determination of human PON3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 6.25-400 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2130 Rat Adenosine Receptor A2a ELISA Kit (AC3541) Quantitative inquiry ASET-2168 Rat Jagged1 ELISA Kit (AC3579) Quantitative inquiry ASET-1766 Mouse Syndecan 4 ELISA Kit (AC3177) Quantitative inquiry ASET-1643 Human GALC ELISA Kit (AC3054) Quantitative inquiry ASET-2150 Mouse Thrombospondin 1 ELISA Kit (AC3561) Quantitative inquiry ASET-2480 Human WFS1 ELISA Kit (AC3891) Quantitative inquiry ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry ASET-1535 Rat Prostate Specific Antigen ELISA Kit (AC2946) Quantitative inquiry ASET-1628 Human HAS3 ELISA Kit (AC3039) Quantitative inquiry ASET-1562 Rat PON1 ELISA Kit (AC2973) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket